These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy]. Duléry R; Giraud C; Beaumont JL; Bilger K; Borel C; Dhedin N; Thiebaut A; Willems E; Alain S; Alfandari S; Dewilde A; Jouet JP; Milpied N; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):158-9. PubMed ID: 24011965 [TBL] [Abstract][Full Text] [Related]
6. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders]. Cornillon J; Vantyghem MC; Couturier MA; de Berranger E; François S; Hermet E; Maillard N; Marcais A; Tabrizi R; Decanter C; Duléry R; Bauters F; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):168-70. PubMed ID: 24011967 [TBL] [Abstract][Full Text] [Related]
7. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility]. Cornillon J; Decanter C; Couturier MA; de Berranger E; François S; Hermet E; Maillard N; Marcais A; Tabrizi R; Vantyghem MC; Bauters F; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):164-7. PubMed ID: 24011968 [TBL] [Abstract][Full Text] [Related]
8. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204 [TBL] [Abstract][Full Text] [Related]
9. [Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC]. Michel G; Detrait M; Elsermans V; Faucher C; Hicheri Y; Ivanova-Derin R; Lemarie C; Sirvent A; Top I; Garnier F; Boulanger F; Michallet M; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):147-8. PubMed ID: 24011969 [TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease. Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656 [TBL] [Abstract][Full Text] [Related]
11. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis]. Cornillon J; Vantyghem MC; Couturier MA; de Berranger E; François S; Hermete E; Maillard N; Marcais A; Tabrizi R; Decanter C; Duléry R; Bauters F; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):171-3. PubMed ID: 24011963 [TBL] [Abstract][Full Text] [Related]
15. [A report of the SFGM-TC on the interactions between national transplant coordination and local coordinators in allogeneic stem cell transplantation activity]. Wallart A; Parguey V; de Bentzmann N; Bompoint C; Fournier I; Godin S; Lebars L; Maurer N; Porcheron S; Premel C; Renaud B; Boulanger F; Fort M; Marry E; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):144-6. PubMed ID: 24011962 [TBL] [Abstract][Full Text] [Related]
16. [Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC]. Loiseau P; Dubois V; Bonafoux B; Bulabois CE; Coiteux V; Eliaou JF; Labaky M; Michallet M; Renac V; Delbos F; Kennel A; Detrait M; Devys A; Galambrun C; Yakoub-Agha I; Pathol Biol (Paris); 2014 Aug; 62(4):226-9. PubMed ID: 24973858 [TBL] [Abstract][Full Text] [Related]
17. [Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC]. Guillaume T; Porcheron S; Audat F; Bancillon N; Berceanu A; Charbonnier A; Dulery R; Edy N; El Cheikh J; Hermet E; Maurer N; Paul F; Konopacki-Potet J; Turlure P; Wallart A; Boulanger F; Dhédin N; Suarez F; Yakoub-Agha I; Pathol Biol (Paris); 2014 Aug; 62(4):193-6. PubMed ID: 24996843 [TBL] [Abstract][Full Text] [Related]
18. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT. de Pagter PJ; Schuurman R; Keukens L; Schutten M; Cornelissen JJ; van Baarle D; Fries E; Sanders EA; Minnema MC; van der Holt BR; Meijer E; Boelens JJ Bone Marrow Transplant; 2013 Nov; 48(11):1460-4. PubMed ID: 23771003 [TBL] [Abstract][Full Text] [Related]